The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions
Clinical trial NCT06244407 · UNKNOWN
Trial details
- NCT number
- NCT06244407
- Sponsor
- International Bio service
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-23
- Primary completion
- 2024-05-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.